Modulation of protein-protein interactions with small organic molecules

被引:257
作者
Berg, T [1 ]
机构
[1] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany
关键词
drug design; high-throughput screening; medicinal chemistry; molecular biology; protein-protein interactions;
D O I
10.1002/anie.200200558
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Many proteins exert their biological roles as components of complexes, and the functions of proteins are often determined by their specific interactions with other proteins. Because of the central importance of protein-protein interactions for cellular processes, the ability to interfere with specific protein-protein interactions provides a powerful means of influencing the function of selected proteins within the cell. Cell-permeable small organic modulators of protein-protein interactions are thus highly desirable tools both for the study of physiological cellular processes and for the treatment of numerous diseased states. Herein a number of protein-protein interactions that are considered to be pharmaceutical targets are presented, which will familiarize the reader with the strategies that have been employed for the successful identification of small molecule modulators of these protein-protein interactions. These encouraging examples suggest that combined research efforts in the areas of functional proteomics, assay development, and organic synthesis will open up novel possibilities for the treatment of human diseases in the future.
引用
收藏
页码:2462 / 2481
页数:20
相关论文
共 272 条
  • [1] Converting a peptide into a drug: Strategies to improve stability and bioavailability
    Adessi, C
    Soto, C
    [J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (09) : 963 - 978
  • [2] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT
    ALBERTS, AW
    CHEN, J
    KURON, G
    HUNT, V
    HUFF, J
    HOFFMAN, C
    ROTHROCK, J
    LOPEZ, M
    JOSHUA, H
    HARRIS, E
    PATCHETT, A
    MONAGHAN, R
    CURRIE, S
    STAPLEY, E
    ALBERSSCHONBERG, G
    HENSENS, O
    HIRSHFIELD, J
    HOOGSTEEN, K
    LIESCH, J
    SPRINGER, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07): : 3957 - 3961
  • [3] Nitric oxide synthases: structure, function and inhibition
    Alderton, WK
    Cooper, CE
    Knowles, RG
    [J]. BIOCHEMICAL JOURNAL, 2001, 357 (03) : 593 - 615
  • [4] A versatile synthetic dimerizer for the regulation of protein-protein interactions
    Amara, JF
    Clackson, T
    Rivera, VM
    Guo, T
    Keenan, T
    Natesan, S
    Pollock, R
    Yang, W
    Courage, NL
    Holt, DA
    Gilman, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10618 - 10623
  • [5] ONCOGENIC ACTIVITY OF THE C-MYC PROTEIN REQUIRES DIMERIZATION WITH MAX
    AMATI, B
    BROOKS, MW
    LEVY, N
    LITTLEWOOD, TD
    EVAN, GI
    LAND, H
    [J]. CELL, 1993, 72 (02) : 233 - 245
  • [6] Crystal structure of rat Bcl-x(L) - Implications for the function of the Bcl-2 protein family
    Aritomi, M
    Kunishima, N
    Inohara, N
    Ishibashi, Y
    Ohta, S
    Morikawa, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) : 27886 - 27892
  • [7] THYROID-HORMONE TRANSPORT PROTEINS
    BARTALENA, L
    ROBBINS, J
    [J]. CLINICS IN LABORATORY MEDICINE, 1993, 13 (03) : 583 - 598
  • [8] Signal transduction by tumor necrosis factor and its relatives
    Baud, V
    Karin, M
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (09) : 372 - 377
  • [9] Discovering transthyretin amyloid fibril inhibitors by limited screening
    Baures, PW
    Peterson, SA
    Kelly, JW
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (08) : 1389 - 1401
  • [10] Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid
    Baures, PW
    Oza, VB
    Peterson, SA
    Kelly, JW
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (07) : 1339 - 1347